Literature DB >> 9640880

Permeability barrier abnormality of hairless mouse epidermis after topical corticosteroid: characterization of stratum corneum lipids by ruthenium tetroxide staining and high-performance thin-layer chromatography.

H M Sheu1, J Y Lee, K W Kuo, J C Tsai.   

Abstract

Topical corticosteroids (TCS) are among the most frequently used topical therapeutics. Recently, it has been shown that TCS not only has antiproliferative actions, but also inhibits the differentiation of the epidermis and finally perturbates stratum corneum (s.c.) barrier function. It is well established that epidermal barrier function resides within the intercellular lipids of the SC. However, to date, little is known about the effects of TCS on the structure and composition of s.c. lipids. We therefore used hairless mouse skin to study the sequential changes of the s.c. permeability barrier and their intercellular lipids by ruthenium tetroxide staining and high-performance thin-layer chromatography (HPTLC) during topical use of corticosteroids. The results demonstrated a progressive increase in transepidermal water loss accompanied by a diminution in the SC intercellular lipid lamellae, which showed a normal structure of individual lamella. Analysis of lipid composition by HPTLC after a 6-week application of TCS also showed an obvious decrease in all the main components of s.c. lipids, which are known to constitute the permeability barrier of the skin. In light of these results, our work provides direct morphological evidence that TCS deteriorates the permeability barrier of epidermis when applied to normal skin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9640880     DOI: 10.1111/j.1346-8138.1998.tb02399.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  6 in total

1.  Test systems for the determination of glucocorticoid receptor ligand induced skin atrophy.

Authors:  Stefanie Schoepe; Heike Schäcke; Khusru Asadullah
Journal:  Dermatoendocrinol       Date:  2011-07-01

2.  Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens.

Authors:  Tiffany C Scharschmidt; Mao-Qiang Man; Yutaka Hatano; Debra Crumrine; Roshan Gunathilake; John P Sundberg; Kathleen A Silva; Theodora M Mauro; Melanie Hupe; Soyun Cho; Yan Wu; Anna Celli; Matthias Schmuth; Kenneth R Feingold; Peter M Elias
Journal:  J Allergy Clin Immunol       Date:  2009-09       Impact factor: 10.793

3.  Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids.

Authors:  Hyun Jung Kim; Hyun Jung Park; Jae Nam Yun; Se Kyoo Jeong; Sung Ku Ahn; Seung Hun Lee
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-14       Impact factor: 5.764

Review 4.  Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.

Authors:  Sean Yilong Tan; Nisha Suyien Chandran; Ellie Ci-En Choi
Journal:  Clin Drug Investig       Date:  2021-08-18       Impact factor: 2.859

5.  Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 Contributes to Epidermal Permeability Barrier Dysfunction in Aged Skin.

Authors:  Beom Jun Kim; Noo Ri Lee; Chung Hyeok Lee; Young Bin Lee; Sung Jay Choe; Solam Lee; Hyun Jee Hwang; Eunjung Kim; Gareth G Lavery; Kyong-Oh Shin; Kyungho Park; Eung Ho Choi
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

6.  Paradoxical benefits of psychological stress in inflammatory dermatoses models are glucocorticoid mediated.

Authors:  Tzu-Kai Lin; Mao-Qiang Man; Juan-Luis Santiago; Tiffany C Scharschmidt; Melanie Hupe; Gemma Martin-Ezquerra; Jong-Kyung Youm; Yongjiao Zhai; Carles Trullas; Kenneth R Feingold; Peter M Elias
Journal:  J Invest Dermatol       Date:  2014-07-03       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.